Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoglitazone Phase 2a in Type 2 Diabetes
NCT00760578Phase 2Completed
- Sponsor
- Metabolic Solutions Development Company
- Start
- Sep 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mitoglitazone in type 2 diabetes mellitus (T2DM), sponsored by Metabolic Solutions Development Company. Started Sep 2008; status: completed.
02
Drugs
Mitoglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00760578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760578.